These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2225381)
1. Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. Califf RM; Harrelson-Woodlief L; Topol EJ Circulation; 1990 Nov; 82(5):1847-53. PubMed ID: 2225381 [TBL] [Abstract][Full Text] [Related]
2. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. Braunwald E; Cannon CP; McCabe CH Circulation; 1992 Aug; 86(2):683-7. PubMed ID: 1638732 [No Abstract] [Full Text] [Related]
3. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Zijlstra F; de Boer MJ; Beukema WP; Liem AL; Reiffers S; Huysmans D; Hoorntje JC; Suryapranata H; Simoons ML Eur Heart J; 1996 Mar; 17(3):382-7. PubMed ID: 8737211 [TBL] [Abstract][Full Text] [Related]
4. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction. Cannon CP; Sharis PJ; Schweiger MJ; McCabe CH; Diver DJ; Shah PK; Sequeira RF; Greene RM; Perritt RL; Poole WK; Braunwald E Am J Cardiol; 1997 Sep; 80(6):696-9. PubMed ID: 9315571 [TBL] [Abstract][Full Text] [Related]
5. Use of left ventricular function as an end point of thrombolytic therapy. Bassand JP; Anguenot T; Cassagnes J; Lusson JR; Machecourt J; Wolf JE Am J Cardiol; 1991 Dec; 68(16):23E-29E. PubMed ID: 1746448 [TBL] [Abstract][Full Text] [Related]
6. Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. O'Connor CM; Califf RM; Massey EW; Mark DB; Kereiakes DJ; Candela RJ; Abbottsmith C; George B; Stack RS; Aronson L J Am Coll Cardiol; 1990 Sep; 16(3):533-40. PubMed ID: 2117618 [TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. Zijlstra F; Beukema WP; van 't Hof AW; Liem A; Reiffers S; Hoorntje JC; Suryapranata H; de Boer MJ J Am Coll Cardiol; 1997 Apr; 29(5):908-12. PubMed ID: 9120174 [TBL] [Abstract][Full Text] [Related]
16. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. Zaret BL; Wackers FJ; Terrin ML; Forman SA; Williams DO; Knatterud GL; Braunwald E J Am Coll Cardiol; 1995 Jul; 26(1):73-9. PubMed ID: 7797778 [TBL] [Abstract][Full Text] [Related]
17. WITHDRAWN: Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cucherat M; Bonnefoy E; Tremeau G Cochrane Database Syst Rev; 2007 Jul; 2003(3):CD001560. PubMed ID: 17636680 [TBL] [Abstract][Full Text] [Related]
18. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cucherat M; Bonnefoy E; Tremeau G Cochrane Database Syst Rev; 2003; (3):CD001560. PubMed ID: 12917910 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group. Gosselink AT; Liem AL; Reiffers S; Zijlstra F Clin Cardiol; 1998 Apr; 21(4):254-60. PubMed ID: 9562935 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. Hohnloser SH; Klingenheben T; Zabel M; Schöpperl M; Mauss O J Am Coll Cardiol; 1999 Jun; 33(7):1895-902. PubMed ID: 10362190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]